CHAPTER 1. Industry Overview of Transcatheter Embolization and Occlusion Devices Market
1.1. Definition and Scope
1.1.1. Definition of Transcatheter Embolization and Occlusion Devices
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Transcatheter Embolization and Occlusion Devices Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Transcatheter Embolization and Occlusion Devices Market By Type
1.2.3. Transcatheter Embolization and Occlusion Devices Market By Application
1.2.4. Transcatheter Embolization and Occlusion Devices Market By End-User
1.2.5. Transcatheter Embolization and Occlusion Devices Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Transcatheter Embolization and Occlusion Devices Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Transcatheter Embolization and Occlusion Devices Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Transcatheter Embolization and Occlusion Devices Market By Type
5.1. Introduction
5.2. Transcatheter Embolization and Occlusion Devices Revenue By Type
5.2.1. Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast, By Type, 2020-2032
5.2.2. Coil
5.2.2.1. Coil Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Pushable Coils
5.2.2.2.1. Pushable Coils Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Detachable Coils
5.2.2.3.1. Detachable Coils Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Non Coil
5.2.3.1. Non-Coil Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.2. Flow Diverting Devices
5.2.3.2.1. Flow Diverting Devices Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.3. Embolization Particles
5.2.3.3.1. Embolization Particles Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.4. Liquid Embolics
5.2.3.4.1. Liquid Embolic Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.5. Others
5.2.3.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Transcatheter Embolization and Occlusion Devices Market By Application
6.1. Introduction
6.2. Transcatheter Embolization and Occlusion Devices Revenue By Application
6.2.1. Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast, By Application, 2020-2032
6.2.2. Peripheral Vascular Disease
6.2.2.1. Peripheral Vascular Disease Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.2. Arterial Blockage
6.2.2.2.1. Arterial Blockage Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.3. Venous Blood clot
6.2.2.3.1. Venous Blood Clot Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.2.4. Others
6.2.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Oncology
6.2.3.1. Oncology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.2. Liver Cancer
6.2.3.2.1. Liver Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.3. Pancreatic Cancer
6.2.3.3.1. Pancreatic Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.4. Breast Cancer
6.2.3.4.1. Breast Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.5. Kidney Cancer
6.2.3.5.1. Kidney Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3.6. Others
6.2.3.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Neurology
6.2.4.1. Neurology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4.2. Brain Aneurysm
6.2.4.2.1. Brain Aneurysm Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4.3. Cerebral Arteriovenous Malformations
6.2.4.3.1. Cerebral Arteriovenous Malformations Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4.4. Others
6.2.4.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Urology
6.2.5.1. Urology Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5.2. Benign Prostatic Hyperplasia/Urinary Retention
6.2.5.2.1. Benign Prostatic Hyperplasia/Urinary Retention Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5.3. Others (Varicocele)
6.2.5.3.1. Others (Varicocele) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.6. Others
6.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Transcatheter Embolization and Occlusion Devices Market By End-User
7.1. Introduction
7.2. Transcatheter Embolization and Occlusion Devices Revenue By End-User
7.2.1. Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast, By End-User, 2020-2032
7.2.2. Hospitals & Clinics
7.2.2.1. Hospitals & Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Ambulatory Surgical Centers
7.2.3.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Others
7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Transcatheter Embolization and Occlusion Devices Market By Country
8.1. North America Transcatheter Embolization and Occlusion Devices Market Overview
8.2. U.S.
8.2.1. U.S. Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
8.2.2. U.S. Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
8.2.3. U.S. Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.3. Canada
8.3.1. Canada Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
8.3.2. Canada Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
8.3.3. Canada Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Transcatheter Embolization and Occlusion Devices Market By Country
9.1. Europe Transcatheter Embolization and Occlusion Devices Market Overview
9.2. U.K.
9.2.1. U.K. Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
9.2.2. U.K. Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.3. U.K. Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Germany
9.3.1. Germany Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
9.3.2. Germany Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.3. Germany Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. France
9.4.1. France Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
9.4.2. France Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
9.4.3. France Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.5. Spain
9.5.1. Spain Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
9.5.2. Spain Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
9.5.3. Spain Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
9.6.2. Rest of Europe Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
9.6.3. Rest of Europe Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Transcatheter Embolization and Occlusion Devices Market By Country
10.1. Asia Pacific Transcatheter Embolization and Occlusion Devices Market Overview
10.2. China
10.2.1. China Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
10.2.2. China Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.3. China Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Japan
10.3.1. Japan Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
10.3.2. Japan Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.3. Japan Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. India
10.4.1. India Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
10.4.2. India Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.3. India Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Australia
10.5.1. Australia Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
10.5.2. Australia Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.3. Australia Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.6. South Korea
10.6.1. South Korea Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
10.6.2. South Korea Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.3. South Korea Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
10.7.2. Rest of Asia-Pacific Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
10.7.3. Rest of Asia-Pacific Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Transcatheter Embolization and Occlusion Devices Market By Country
11.1. Latin America Transcatheter Embolization and Occlusion Devices Market Overview
11.2. Brazil
11.2.1. Brazil Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
11.2.2. Brazil Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.3. Brazil Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. Mexico
11.3.1. Mexico Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
11.3.2. Mexico Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.3. Mexico Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
11.4.2. Rest of Latin America Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.3. Rest of Latin America Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market By Country
12.1. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market Overview
12.2. GCC
12.2.1. GCC Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
12.2.2. GCC Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.3. GCC Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.3. South Africa
12.3.1. South Africa Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
12.3.2. South Africa Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.3. South Africa Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Type, 2020-2032
12.4.2. Rest of Middle East & Africa Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.3. Rest of Middle East & Africa Transcatheter Embolization and Occlusion Devices Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Transcatheter Embolization and Occlusion Devices Market
13.1. Transcatheter Embolization and Occlusion Devices Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Transcatheter Embolization and Occlusion Devices Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. Abbott
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Billion), 2022
14.1.3.2. Abbott 2022 Transcatheter Embolization and Occlusion Devices Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Boston Scientific Corporation
14.3. Cordis Corporation
14.4. Cook Medical
14.5. DePuy Synthes
14.6. Medtronic, Inc.
14.7. Nordian
14.8. Sirtex Medical
14.9. St. Jude Medical
14.10. Stryker Corporation
14.11. Terumo Corporation
14.12. Pfizer Inc.
The market size of transcatheter embolization and occlusion devices was USD 4.9 Billion in 2022.
The CAGR of transcatheter embolization and occlusion devices is 9.3% during the analysis period of 2023 to 2032.
The key players operating in the global market are including Abbott, Boston Scientific Corporation, Cordis Corporation, Cook Medical, DePuy Synthes, Medtronic, Inc., Nordian, Sirtex Medical, St. Jude Medical, Stryker Corporation, Terumo Corporation, and Pfizer Inc.
North America held the dominating position in transcatheter embolization and occlusion devices industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of transcatheter embolization and occlusion devices during the analysis period of 2023 to 2032.
The current trends and dynamics in the transcatheter embolization and occlusion devices industry include growing demand for minimally invasive procedures, advantages like reduced recovery time and blood loss, increasing incidence of venous malformations, and technological advancements enhancing device efficacy.
The non coil type held the maximum share of the transcatheter embolization and occlusion devices industry.?
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date